the aid library

LIST OPTIONS

Filter

2048

Sort by:

Direction:

Download (85)

View PDF (130)

Chronic HIV Care with ARV Therapy and Prevention

World Health Organization (2007) C_WHO

Integrated Management of Adolescent and Adult Illness Integrated Management of Childhood Illness Interim Guidelines for health workers at health centre or district hospital outpatient clinic

Download (854)

View PDF (1299)

Global report on psoriasis

World Health Organization WHO (2016) C_WHO

Psoriasis, which can involve the skin, nails and joints, is a chronic, painful, disfiguring and disabling noncommunicable disease (NCD) for which there is no cure. It negatively impacts on quality of life. Some of those who suffer from the disease develop chronic, inflammatory arthritis (psoriatic a... more

Download (372)

View PDF (620)

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
recommended

World Health Organization WHO (2019) C_WHO

The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel... more

Download (109)

View PDF (150)

Signs and symptoms of chronic HIV disease

G. Rogers; A. Mijch; A. Brotherton ResearchGate.net (2008) C2

Article, January 2008

Download (798)

View PDF (1495)

Directrices de la OMS sobre el tratamiento farmacológico del dolor persistente en niños con enfermedades médicas

World Health Organization (2012)

The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-... more

Download (764)

View PDF (1614)

WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses

World Health Organization (2012)

Download (227)

View PDF (401)

Chronic suppurative otitis media - Burden of Illness and Management Options

World Health Organization (WHO) (2004) C_WHO

Download (124)

View PDF (136)

Standard treatment guidelines oncology India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (138)

View PDF (183)

Guidelines on the management of chronic pain in children

World Health Organization WHO (2020) C_WHO

Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols

Download (316)

View PDF (445)

Chronic Care for Neglected Infectious Diseases: Leprosy/Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease

Pan American Health Organisation PAHO (2021) C_WHO

This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u... more

Download (108)

View PDF (144)

Disease Control Priorities 3: Palliative Care and Pain Control

World Bank (2018) C1

Palliative care has been shown to provide significant and diverse benefits for patients with serious, complex,or life-limiting health problem. Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R., editors. Disease Control Priorities, 3rd Edition, Volume 9: Improving Health an... more

Download (125)

View PDF (146)

Améliorer la disponibilité et l'accessibilité des médicaments analgesiques à l'échelle mondiale : un cadre de travail pour évaluer les politiques nationales qui régissent les médicaments opioïdes

Pain & Policy Studies Group (2018) CC

Groupe d'étude sur la douleur et les politiques / Centre collaborateur de l'OMS pour les politiques de soulagement de la douleur et de soins palliatifs

Download (73)

View PDF (509)

Buruli Ulcer Disease: Buruli Nodule

OER Africa (2012) CC

Buruli ulcer is a chronic, progressive skin disease caused by infection with Mycobacterium ulcerans. It is currently considered to be one of the neglected tropical diseases; less common than tuberculosis but more common than leprosy. The initial lesion is a painless subcutaneous nodule, usually less... more

Download (75)

View PDF (251)

The Expanded Special Project for Elimination of Neglected Tropical diseases — ESPEN

World Health Organization WHO (2023) C_WHO

Accessed on 10.04.2023 While virtually unheard of in developed countries, NTDs are a group of medically diverse parasitic and bacterial infectious diseases common in tropical and subtropical areas. NTDs affect more than 1.5 billion people annually, causing death, blindness, disfigurement, chroni... more

Download (76)

View PDF (136)

Soil-transmitted helminthiases

World Health Organization WHO (2020) C_WHO

oil-transmitted helminth (STH) infections are among the most common infections worldwide and affect the poorest and most deprived communities. They are transmitted by eggs present in human faeces which in turn contaminate soil in areas where sanitation is poor. The main species that infect peopl... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (117)

View PDF (104)

WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings

World Health Organization WHO (2023) CC

The purpose of the guideline is to provide evidence-based recommendations on nonsurgical interventions for chronic primary LBP (CPLBP) in adults, including older people, that can be delivered in primary and community care settings to improve CPLBP-related health and well-being outcomes. For this rea... more

Download (117)

View PDF (107)

WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings

World Health Organization WHO (2023) CC

Download (15)

View PDF (15)

Health Technology MANUAL: Improving the Integrated Management of Chronic Diseases at the First Level of Health Care Services

Pan American Health Organization PAHO; World Health Organization WHO (2017) C_WHO

Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,... more

Download (65)

View PDF (63)

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended

World Health Organisation (WHO) (2024) C_WHO

Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical disease (NTD) is endemic globally, predominately in the South-East Asia, Afric... more

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents recommended

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis ﻿ recommended

WHO Guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents
recommended

WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended